News
MCK
536.85
-0.45%
-2.41
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
NASDAQ · 22h ago
Peering Into McKesson's Recent Short Interest
McKesson's short percent of float has risen 9.17% since its last report. The company has 1.72 million shares sold short, which is 1.31% of all regular shares available for trading. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 1d ago
Press Release: McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date
McKesson Corporation will release its fourth quarter and full year fiscal 2024 financial results after market close on May 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time. McKesson is a diversified healthcare services leader.
Dow Jones · 1d ago
Rite Aid Forges Path To Financial Recovery With Major Settlement: Report
Pharmacy chain Rite Aid Corp has reportedly reached a settlement with its lenders, the U.S. Department of Justice, and drug supplier McKesson. The settlement will pave the way for the conclusion of its bankruptcy case by late April. Rite Aid filed for bankruptcy in October last year.
Benzinga · 2d ago
Rite Aid inks bankruptcy deal with stakeholders including McKesson
Healthcare Rite Aid inks bankruptcy deal with stakeholders including McKesson. Rite Aid filed for Chapter 11 bankruptcy in October. Pharmacy chain expected to seek court approval to gather votes for its bankruptcy plan by April 22. The company is burdened by billions of dollars in debt.
Seeking Alpha · 2d ago
UPDATE 1-Rite Aid reaches bankruptcy settlement with lenders, DOJ, McKesson
Rite Aid reaches bankruptcy settlement with lenders, DOJ, drug supplier McKesson. Pharmacy chain faced over 1,600 lawsuits over its sale of opioid medications. Rite Aid filed for bankruptcy in October. The deal has the support of creditors who sued Rite Aid over the sale of the drugs.
Reuters · 2d ago
TDVG: Dividend Growth ETF Beating Its Peers For 12 Months
T. Rowe Price Dividend Growth ETF is an actively managed fund with selection criteria based on dividend growth, quality and valuation. The fund is close to the S&P 500 regarding valuation, inferior in earnings growth and superior in quality. TDVG is among the best of its peers in total return and dividend growth rate.
Seeking Alpha · 3d ago
Weekly Report: what happened at MCK last week (0318-0322)?
Weekly Report · 4d ago
Here's Why You Should Hold McKesson (MCK) in Your Portfolio
NASDAQ · 03/22 13:15
Becton, Dickinson boosts syringe production amid FDA concerns on supplies
Healthcare Becton, Dickinson boosts syringe production amid FDA concerns on supplies. FDA warned about quality issues linked to plastic syringes made in China. The company has increased the U.S. Production of syringe in its Nebraska and Connecticut plants. BD says the company has capacity to fulfill additional customer demand.
Seeking Alpha · 03/21 14:22
4th Circuit sends West Virginia city's opioid case to state's top court
4th Circuit sends West Virginia city's opioid case to state's top court. The city and county of Huntington and Cabell County sued top drug distributors over the opioid crisis. A lower court rejected their case in 2022. The 4th Circuit sent the case to the state's highest court.
Reuters · 03/18 18:33
Weekly Report: what happened at MCK last week (0311-0315)?
Weekly Report · 03/18 09:08
Which Stocks Will Dominate The Future Of Tech? UBS Shares Its Top Picks In AI, Healthtech, Greentech, And Fintech
Global wealth manager UBS has identified the sectors that will produce the "next big thing" in tech. The bank has identified artificial intelligence, cybersecurity, health tech, Greentech, and fintech as the sectors. UBS identified 29 companies that are expected to experience superior earnings growth.
Benzinga · 03/18 07:14
Noteworthy Thursday Option Activity: M, QCOM, MCK
NASDAQ · 03/14 19:20
FACTBOX-What has UnitedHealth restored and what is next after major hack?
UnitedHealth has brought back online the pharmacy systems at its Change Healthcare technology unit. The company expects the payment platform to be functional and begin restoring medical claims starting mid-March. The Feb. 21 cyberattack disrupted the U.S. Healthcare system. UnitedHealth is likely to several months to make a full recovery.
Reuters · 03/14 17:44
Interesting MCK Put And Call Options For November 15th
NASDAQ · 03/14 14:45
UnitedHealth's (UNH) Payment System Disrupted by Cyberattack
NASDAQ · 03/14 12:28
Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?
McKesson Corporation is estimated to be 43% undervalued based on current share price of US$520. The projected fair value for McKesson is US$914 based on 2 Stage Free Cash Flow to Equity. We will use the Discounted Cash Flow model to estimate the company's intrinsic value. The company is valued at a 43% discount to its current value.
Simply Wall St · 03/14 10:54
BUZZ-Brokerage says UnitedHealth hack may lead to pick up in volumes for Mckesson
Brokerage says UnitedHealth hack may lead to pick up in volumes for drug distributor McKesson MCK.N. Leerink says the hack at UnitedHealth's Change Healthcare processes insurance claims and payments for the industry. Change Healthcare was breached on Feb. 21 by a hacking group.
Reuters · 03/13 11:47
McKesson whistleblower's kickback lawsuit is revived
McKesson whistleblower's kickback lawsuit is revived. Whistleblower accused McKesson of providing drug pricing tools to doctors to induce them to purchase drugs from the company. The decision restores claims by Adam Hart, a former McKesson business development executive, court says.
Reuters · 03/12 13:02
More
Webull provides a variety of real-time MCK stock news. You can receive the latest news about McKesson through multiple platforms. This information may help you make smarter investment decisions.
About MCK
McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada.